Primary hyperoxaluria type 1 (PH 1 ) is an autosomal recessive inborn error of glyoxylate metabolism caused by a deficiency of the hepatic peroxisomal enzyme alanine-glyoxylate aminotransferase (ACT; EC 2.6.1.44) (Danpure & Jennings, 1986) . Only a minority of these ACT-deficient patients (three out of 12) possess detectable amounts of immunoreactive AGT protein ( C R M + ) (Wise et al., 1987) . The aim of the present study is to use immunocytochemical methods to investigate the intracellular distribution of AGT protein in normal human liver and in the livers of PHI patients (both CRM + and CRM -).
Fresh liver biopsies, from three controls, a PHI heterozygote and four PH 1 homozygotes, were fixed in 1% or 3"/0 glutaraldehyde and embedded in Lowicryl K4M (Carlemalm ct ul., 1982) for post-embedding immunocytochemistry with the protein A-gold technique (Roth, 1982) . Anti-human ACT antiserum was raised in rabbits as described previously (Wise et al.. 1987) . The immunogenicity of the AGT protein was unaffected by glutaraldehyde fixation as judged by dotblotting (Moeremans el ul., 1984) .
In all the CRM + liver samples (i.e. normals, heterozygote and CRM + homozygote), the immunoreactive AGT protein was entirely confined to the peroxisomes (Fig. 1 ). Liver from CRM -patients showed no labelling of the peroxisomes, any other organelles or cytosol. Subcellular fractionation of human liver homogenates has demonstrated the peroxisomal localization of ACT enzyme activity (Noguchi & Takada, 1979) and immunoreactive ACT protein (Wise et al., 1987) . In the PH 1 heterozygote, who possessed approximately 50% ACT enzyme activity (C. J. Danpure & P. R. Jennings, unpublished work), the density of labelling for immunoreactive ACT protein was similarly reduced compared with the Abbreviations used: PHI, primary hyperoxaluria type I ; ACT, alanine-glyoxylate aminotransferase (EC 2.6.1.44); CRM + , CRM -, immunoreactive ACT present or absent, respectively. control livers. In the CRM+ PHI patient, who had a complete deficiency of AGT enzyme activity, the density and distribution of gold labelling was similar to the controls. The increased immunoreactive ACT protein found in liver homogenates from this patient by immunoblotting (P. J. Wise & C. J. Danpure, unpublished work) may be due to peroxisoma1 proliferation.
AGT immunoreactive protein is clearly randomly distributed across the peroxisomal matrix, with no evidence of 
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BIOCHEMICAL SOCIETY TRANSACTIONS preferential membrane localization (Fig. 1 ) . These results are at variance with the findings of Chandoga et al. (1986) , who, using subcellular fractionation techniques, found that the majority of the AGT enzyme activity was bound to the peroxisomal membrane. In the light of the evidence presented here, the suggested membrane localization of AGT is likely to be an artefact due to non-specific adsorption.
Notwithstanding the lower efficiency of detection of randomly dispersed cytoplasmic proteins by immunocytochemical methods (Kellenberger et al., 1987) , we have found no evidence of any cytosolic localization of AGT. Tissue homogenization, which is a prerequisite for subcellular fractionation, can lead to leakage of peroxisomal enzymes, including AGT, into the cytosolic fractions (Noguchi et af.,  1979) . However, the negligible background staining in the present study agrees with the previous suggestion (Danpure & Jennings, 1986; Danpure et al., 1987) that the apparent cytosolic AGT activity found on sucrose density gradients is due to a different and immunologically unrelated enzyme, namely g1utamate:glyoxylate aminotransferase (EC 2.6.1.4).
Introduction
The biological activity of gastrin is known to reside in the C-terminal tetrapeptide, Trp-Met-Asp-Phe-NH, (Tracy & Abbreviation used: IPA-Leu-Asp-PEA, indole-3-propionyl-~-leucyl-L-aspart yl-phenethylamide. Gregory, 1964) . Morley ( 1968) carried out extensive structure-function studies and determined that Trp, Asp and Phe-NH, are essential for this activity, although specific alterations of Trp and Phe side-chains are tolerated. The tetrapeptide sequence in which tryptophan was substituted by indole-3-propionic acid was found to be as active as tetragastrin.
Martinez et al. (1986) prepared a number of C-terminal analogues containing phenethylamine in place of Phe-NH,. All the peptides containing this substitution were subsequently shown to be potent inhibitors of gastric acid secretion.
We have prepared the peptide indole-3-propionyl-~-leucyl-L-aspartyl-phenethylamide (IPA-Leu-Asp-PEA) by Time (min) 
